Table 1 Clinical characteristics of the study sample

From: Association between prefrontal glutamine levels and neuroticism determined using proton magnetic resonance spectroscopy

 

Healthy

MDD only

Anxiety only

MDD/anx

All

n

84

7

8

11

110

Female (%)

44 (52.3)

5 (71.4)

5 (62.5)

7 (63.6)

61 (55.5)

Age [y] (M, (SD))

23.8 (3.9)

26.9 (8.1)

24.6 (2.3)

27.8 (2.8)

24.5 (4.3)

Education [y] (M, (SD))

14.0 (2.7)

11.7 (2.5)

15.1 (3.1)

13.7 (3.6)

13.9 (2.9)

Neuroticism NeoFFI (M, (SD))

15.3 (7.0)

24.1 (7.5)

17.1 (3.4)

31.9 (5.9)

17.6 (8.5)

STAI trait (M, (SD))

32.6 (7.3)

43.6 (10.9)

33.0 (3.4)

56.3 (12.0)

35.7 (10.8)

BDI (M, (SD))

2.27 (3.59)

8.50 (3.51)

1.38 (2.56)

16.00 (11.82)

3.94 (6.75)

BAI (M, (SD))

3.13 (3.42)

7.71 (5.94)

3.88 (4.29)

13.00 (11.42)

4.48 (5.80)

  1. This table displays demographics and psychiatric scales of the healthy individuals and those with mood and anxiety disorders. Anxiety disorder includes OCD and PTSD as suggested by DSM-IV